Page last updated: 2024-08-26

imipenem, anhydrous and Renal Insufficiency

imipenem, anhydrous has been researched along with Renal Insufficiency in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's2 (22.22)29.6817
2010's3 (33.33)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Bhagunde, P; Boundy, K; Butterton, JR; Colon-Gonzalez, F; Garrett, G; Jumes, P; Lala, M; Lasseter, K; Liu, Y; Marbury, T; Rhee, EG; Rizk, ML; Wu, J; Xu, SS1
Brown, M; Kantesaria, B; Lala, M; Paschke, A; Rizk, ML; Walker, B1
Chavez-Eng, C; Danhof, M; Kerbusch, T; Lala, M; Rao, G; Rizk, ML; van der Graaf, PH; van Hasselt, JG; Visser, SA1
Ikawa, K; Ikeda, K; Kumon, H; Morikawa, N; Ohge, H; Yoshizawa, K1
Barrero-Almodóvar, AE; Bernabeu-WittelI, M; Gallego-Lara, SL; García-Garmendia, JL; Garnacho-Montero, J; Jiménez-Jiménez, FJ; Madrazo-Osuna, J; Ortiz-Leyba, C1
Haig, GM; Pryka, RD1
Ebira, H; Ikeda, Y; Kihara, M; Masumori, S; Shibata, K; Shionoiri, H; Shiratori, K; Takagi, N; Ueda, S; Umemura, S1
Craig, WA1
Hörl, WH; Thalhammer, F1

Reviews

3 review(s) available for imipenem, anhydrous and Renal Insufficiency

ArticleYear
Meropenem: a new carbapenem antimicrobial.
    The Annals of pharmacotherapy, 1994, Volume: 28, Issue:9

    Topics: Clinical Trials as Topic; Drug Resistance, Microbial; Drugs, Investigational; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Renal Insufficiency; Thienamycins

1994
The pharmacology of meropenem, a new carbapenem antibiotic.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24 Suppl 2

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Child; Child, Preschool; Cilastatin; Clinical Trials as Topic; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infant; Infant, Newborn; Kidney; Male; Meropenem; Microbial Sensitivity Tests; Molecular Structure; Renal Insufficiency; Thienamycins

1997
Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy.
    Clinical pharmacokinetics, 2000, Volume: 39, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Child; Half-Life; Humans; Imipenem; Male; Meropenem; Metabolic Clearance Rate; Renal Dialysis; Renal Insufficiency; Thienamycins

2000

Trials

3 trial(s) available for imipenem, anhydrous and Renal Insufficiency

ArticleYear
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin.
    British journal of clinical pharmacology, 2020, Volume: 86, Issue:5

    Topics: Adult; Aged; Azabicyclo Compounds; beta-Lactamase Inhibitors; Cilastatin; Drug Combinations; Female; Humans; Imipenem; Male; Middle Aged; Organic Anion Transporters; Renal Insufficiency; Young Adult

2020
Simplification of Imipenem Dosing by Removal of Weight-Based Adjustments.
    Journal of clinical pharmacology, 2019, Volume: 59, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Renal Insufficiency; Young Adult

2019
Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid.
    British journal of clinical pharmacology, 2016, Volume: 81, Issue:6

    Topics: Adolescent; Adult; Aged; Bronchoalveolar Lavage Fluid; Female; Healthy Volunteers; Humans; Imipenem; Lung; Male; Meta-Analysis as Topic; Middle Aged; Models, Biological; Renal Insufficiency; Young Adult

2016

Other Studies

3 other study(ies) available for imipenem, anhydrous and Renal Insufficiency

ArticleYear
Optimisation of imipenem regimens in patients with impaired renal function by pharmacokinetic-pharmacodynamic target attainment analysis of plasma and urinary concentration data.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Female; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Plasma; Renal Insufficiency; Time Factors; Urine

2012
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, May-01, Volume: 36, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Pneumonia; Prospective Studies; Renal Insufficiency; Ventilators, Mechanical

2003
Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
    Clinical nephrology, 1994, Volume: 42, Issue:3

    Topics: Aged; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Half-Life; Humans; Imipenem; Infusions, Intravenous; Male; Renal Dialysis; Renal Insufficiency

1994